Back
AnaptysBio Q4 Profit Reverses Loss, Beats Estimates by 78%
Back
Stock News
Themes
AnaptysBio Q4 Profit Reverses Loss, Beats Estimates by 78%
AnaptysBio Q4 Profit Reverses Loss, Beats Estimates by 78%
Edgen Stock
·
Mar 03 2026, 23:46
Share to
Share to
Copy link
ANAB
+4.55%
source:
[1] AnaptysBio, Inc. (ANAB) Q4 Earnings and Revenues Top Estimates
Recommend
Intel Targets AI PC Market With New Core Ultra Processors
Mar 11 2026, 16:34
Synopsys Unveils AI Design Platform Integrating Ansys Tech
Mar 11 2026, 16:30
Nvidia Boosts Agentic AI Throughput 5x with New Model
Mar 11 2026, 16:20
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Themes
Crypto Comparison
Home Page
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
US Market
HK Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2026 Finture Development Limited. All rights reserved